Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose J Lucas

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Molecular Neurodegeneration|February 26, 2017
Spatiotemporal progression of ubiquitin-proteasome system inhibition after status epilepticus suggests protective adaptation against hippocampal injuryTobias Engel, Jaime Martinez-Villarreal, Christine Henke, et al.
Ebiomedicine|May 3, 2024
The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγXuexin Li, Ivó Hernandez, Seda Koyuncu, et al.
The Journal of Biological Chemistry|August 21, 2003
Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418Ratan Bhat, Yafeng Xue, Stefan Berg, et al.
Brain : a Journal of Neurology|January 31, 2013
CHOP regulates the p53-MDM2 axis and is required for neuronal survival after seizuresTobias Engel, Amaya Sanz-Rodgriguez, Eva M Jimenez-Mateos, et al.
Acta Neuropathologica Communications|June 6, 2022
CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington's diseaseDahyun Yu, Nicole Zarate, Angel White, et al.
Acta Neuropathologica Communications|June 22, 2022
Correction to: CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington's diseaseDahyun Yu, Nicole Zarate, Angel White, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Molecular Neurodegeneration|February 26, 2017
Spatiotemporal progression of ubiquitin-proteasome system inhibition after status epilepticus suggests protective adaptation against hippocampal injuryTobias Engel, Jaime Martinez-Villarreal, Christine Henke, et al.
Ebiomedicine|May 3, 2024
The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγXuexin Li, Ivó Hernandez, Seda Koyuncu, et al.
The Journal of Biological Chemistry|August 21, 2003
Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418Ratan Bhat, Yafeng Xue, Stefan Berg, et al.
Brain : a Journal of Neurology|January 31, 2013
CHOP regulates the p53-MDM2 axis and is required for neuronal survival after seizuresTobias Engel, Amaya Sanz-Rodgriguez, Eva M Jimenez-Mateos, et al.
Acta Neuropathologica Communications|June 6, 2022
CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington's diseaseDahyun Yu, Nicole Zarate, Angel White, et al.
Acta Neuropathologica Communications|June 22, 2022
Correction to: CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington's diseaseDahyun Yu, Nicole Zarate, Angel White, et al.
Pageof 2